Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 3
Submit an article Journal homepage
2,248
Views
19
CrossRef citations to date
0
Altmetric
Brief Report

Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses

Grammatiki FotakiDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
,
Chuan JinDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
,
Mohanraj RamachandranDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
,
Iliana Kyriaki KerzeliDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
,
Alex Karlsson-ParraDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;Immunicum AB
,
Di YuDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8636-0351
ORCID Icon &
Magnus EssandDepartment of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
 show all
Article: e1395126 | Received 23 Aug 2017, Accepted 16 Oct 2017, Published online: 27 Nov 2017

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xiaoling Xu, Zichao Zhou, Hui Li & Yun Fan. (2021) Towards customized cancer vaccines: a promising filed in personalized cancer medicine. Expert Review of Vaccines 20:5, pages 545-557.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now

Articles from other publishers (16)

Longyue L. Cao & Jonathan C. Kagan. (2023) Targeting innate immune pathways for cancer immunotherapy. Immunity 56:10, pages 2206-2217.
Crossref
Arwa Ali, Menghan Gao, Alexandros Iskantar, Hai Wang, Alex Karlsson-Parra, Di Yu & Chuan Jin. (2023) Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment. Frontiers in Immunology 14.
Crossref
Sajad Najafi & Keywan Mortezaee. (2023) Advances in dendritic cell vaccination therapy of cancer. Biomedicine & Pharmacotherapy 164, pages 114954.
Crossref
Huazhong Cai, Yongfei Ren, Shuangwei Chen, Yue Wang & Liangmei Chu. (2023) Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors. Frontiers in Oncology 13.
Crossref
Murad Alahdal & Eyad Elkord. (2022) Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities. Clinical Immunology 245, pages 109177.
Crossref
Magnus Lindskog, Anna Laurell, Anders Kjellman, Bohuslav Melichar, Pablo Maroto Rey, Henryk Zieliński, Felipe Villacampa, Pierre Bigot, Bajory Zoltan, Omi Parikh, David Vazquez Alba, Åsa Jellvert, Tibor Flaskó, Enrique Gallardo, Maria José Ribal Caparrós, Gunta Purkalne, Peter Suenaert, Alex Karlsson-Parra & Börje Ljungberg. (2022) Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study. European Urology Open Science 40, pages 38-45.
Crossref
Jean-Pierre Bikorimana, Natasha Salame, Simon Beaudoin, Mohammad Balood, Théo Crosson, Jamilah Abusarah, Sebastien Talbot, Raimar Löbenberg, Sebastien Plouffe & Moutih Rafei. (2022) Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity. Cell Reports Medicine 3:3, pages 100534.
Crossref
Jamilah Abusarah, Fatemeh Khodayarian, Nehme El-Hachem, Natasha Salame, Martin Olivier, Mohammad Balood, Katiane Roversi, Sebastien Talbot, Jean-Pierre Bikorimana, Jingkui Chen, Mario Jolicoeur, Louis-Eric Trudeau, Samaneh Kamyabiazar, Borhane Annabi, Francis Robert, Jerry Pelletier, Abed-El-Hakim El-Kadiry, Riam Shammaa & Moutih Rafei. (2021) Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice. Cell Reports Medicine 2:12, pages 100455.
Crossref
Bram Van Den Eeckhout, Jan Tavernier & Sarah Gerlo. (2021) Interleukin-1 as Innate Mediator of T Cell Immunity. Frontiers in Immunology 11.
Crossref
Shiming Tan, Longzheng Xia, Pin Yi, Yaqian Han, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Linda Oyang, Jiaxin Liang, Jinguan Lin, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou & Qianjin Liao. (2020) Exosomal miRNAs in tumor microenvironment. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Jing Ma, Mohanraj Ramachandran, Chuan Jin, Clara Quijano-Rubio, Miika Martikainen, Di Yu & Magnus Essand. (2020) Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer. Cell Death & Disease 11:1.
Crossref
Chao Wang, Zhengyuan Li, Zhongli Zhu, Yijie Chai, Yiqing Wu, Zhenglong Yuan, Zhijie Chang, Zhao Wang & Minghui Zhang. (2019) Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1+CD8 T cells. Scientific Reports 9:1.
Crossref
Günther Schönrich & Martin J. Raftery. (2019) Dendritic Cells (DCs) as “Fire Accelerants” of Hantaviral Pathogenesis. Viruses 11:9, pages 849.
Crossref
Magnus Rizell, Malin Sternby Eilard, Mats Andersson, Bengt Andersson, Alex Karlsson-Parra & Peter Suenaert. (2019) Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma. Frontiers in Oncology 9.
Crossref
Alex Karlsson-Parra, Juliana Kovacka, Emilia Heimann, Margareth Jorvid, Sijme Zeilemaker, Sharon Longhurst & Peter Suenaert. (2018) Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. Pharmaceutical Research 35:8.
Crossref
Prajakta Shinde, Sophia Fernandes, Sameer Melinkeri, Vaijayanti Kale & Lalita Limaye. (2018) Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy. Scientific Reports 8:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.